Brainstorm Cell Therapeutics (BCLI) Q2 2026 Earnings

1AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Next
-0.97
-0.71
-0.45
-0.19

Details

Expected EPS
-0.28
Actual EPS
N/A
Surprise EPS
0.28
Surprise Percent
+100%

Description

Brainstorm Cell Therapeutics (BCLI) will report earnings of for Q2 2026 on April 01, 2026.

0 Comments

Share your thoughts